ID   BR55-2
AC   CVCL_JY75
SY   BR55.2; Br55-2
DR   ATCC; HB-9324
DR   Wikidata; Q54798149
RX   Patent=US4971792;
RX   Patent=US5182192;
RX   PubMed=2432062;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9324.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI:59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
RX   Patent=US4971792;
RA   Steplewski Z., Koprowski H., Thurin M.;
RT   "Monoclonal antibodies against glycolipid antigens.";
RL   Patent number US4971792, 20-Nov-1990.
//
RX   Patent=US5182192;
RA   Steplewski Z., Koprowski H., Thurin M.;
RT   "Monoclonal antibodies against glycolipid antigens, methods of
RT   producing these antibodies, and use therefor.";
RL   Patent number US5182192, 26-Jan-1993.
//
RX   PubMed=2432062; DOI=10.1016/S0021-9258(19)75937-7;
RA   Blaszczyk-Thurin M., Thurin J., Hindsgaul O., Karlsson K.-A.,
RA   Steplewski Z., Koprowski H.;
RT   "Y and blood group B type 2 glycolipid antigens accumulate in a human
RT   gastric carcinoma cell line as detected by monoclonal antibody.
RT   Isolation and characterization by mass spectrometry and NMR
RT   spectroscopy.";
RL   J. Biol. Chem. 262:372-379(1987).
//